Hints and tips:
Related Special Reports
...“Private equity continues to have a love affair with pharma-adjacent suppliers,” said Robert Darwin, a partner at law firm Sidley Austin and specialist in life sciences transactions....
...This article has been amended to correct Foresite Capital’s name....
...Dmitry Kuzmin, managing partner of 4Bio Capital, said the past year had brought a “peculiar disconnect” between public markets and appetite for private life sciences investments....
...To attract US investors, Northern Ireland has a new life sciences advisory board chaired by Mark Goldstone, partner in New York-based venture capital firm Eckuity, which specialises in early-stage life science...
...Allan Bradley’s T-Therapeutics, a Cambridge university spin-off, is set to unveil the first-round investment led by Sofinnova Partners, F-Prime Capital, Digitalis Ventures and Cambridge Innovation Capital...
...Evan Seigerman, an analyst at BMO Capital Markets, said investors who drove up these stocks in a “sugar-high rush” were now “mentally over the pandemic”....
...The increased funds for Novo Holdings will be split equally between its capital investments and life sciences investments, with Kutay saying Novo Holdings’ investments in larger life sciences companies are...
...The bank said in February that it had raised more than $2bn in seed capital from 27 contributors....
...Several early-stage life sciences investors told the Financial Times the technology was attractive but that the field faced a higher bar for investment than other start-ups....
...McKernan is a former head of Innovate UK and currently a venture partner at life sciences venture capital firm SV Health Investors....
...Silicon Valley’s blue-chip venture capital firm....
...Novavax is this year rolling out its second product: a malaria vaccine approved by the World Health Organization, which will help to grow its revenues from $531.4mn last year to a projected $854.2mn this...
...The biotech group’s investors for this funding round include MSD GHIF, an investment arm of US pharma company MSD, along with UK venture capital group IQ Capital....
...“The late-stage pipeline is on the thinner side relative to other companies,” said Alessandro Valentini at Causeway Capital, a top 25 investor with a 1 per cent stake....
Forerunners of pharma company tested vaccines at notorious institutions for decades
...The early data helped Compass raise $285mn in a private placement of its shares last August from mainstream biotech funds including $10bn fund RA Capital and Surveyor Capital, an equities business owned...
...The country’s National Institute for Health and Care Excellence, the public health body, recommends the drug be used only for people with serious underlying health conditions such as cancer and HIV or recipients...
...But medtech remains one of the biggest growth segments within life sciences in the UK....
...In a 2015 study published in The Annals of the American Academy of Political and Social Science, researchers tested the hypothesis that exposing people to information about how geoengineering can help reduce...
Regulator authorises treatment for sickle cell disease and beta thalassaemia
...WhatsApp to Susan: OK look there’s a chance Labour’s shadow health or science secretaries may drop into these meetings so we can’t just ask the usual types. We need expertise....
...to cause a global health crisis....
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...The World Health Organization last month described dengue fever as a “substantial public health challenge”, noting a “10-fold surge in reported cases worldwide increasing from 500,000 to 5.2mn” between 2000...
...Biotech beauty products are increasingly filling our bathroom cabinets; the science may have been used in a simple way for decades, but new innovations are driving considerable change....
International Edition